Investing.com - Tyra Biosciences (NASDAQ: TYRA) reported third quarter EPS of $-0.49, $0.14 worse than the analyst estimate of $-0.35. Revenue for the quarter came in at $0.00 versus the consensus estimate of $0.00.
Tyra Biosciences's stock price closed at $12.16. It is down -20.99% in the last 3 months and up 62.57% in the last 12 months.
Tyra Biosciences saw 2 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Tyra Biosciences's stock price’s past reactions to earnings here.
According to InvestingPro, Tyra Biosciences's Financial Health score is "good performance".
Check out Tyra Biosciences's recent earnings performance, and Tyra Biosciences's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar